Fig. 2: Co-mutation plot from whole exome sequencing of brain metastasis patients.
Significantly recurrently mutated drivers identified by both MutSig2CV and dNdScv in BM-LUAD are shown, followed by significantly amplified or deleted drivers identified using GISTIC in BM-LUAD, along with additional known cancer drivers in lung adenocarcinoma. Genes highlighted in orange are candidate metastatic drivers identified by matched case-control comparison between BM-LUAD and TCGA-LUAD. Each column represents one brain metastasis. False discovery rates are controlled at 1%.